<DOC>
	<DOCNO>NCT01381341</DOCNO>
	<brief_summary>A pharmacokinetic study compare 2 clinical formulation linifanib .</brief_summary>
	<brief_title>To Compare Relative Bioavailability Two Clinical Formulations Linifanib .</brief_title>
	<detailed_description>This study design evaluate bioavailability linifanib 2 formulation . Subjects may enroll separate extension study continue receive linifanib completion study .</detailed_description>
	<criteria>Inclusion Criteria 1 . Age great equal 18 year . 2 . Subject must histologically cytologically confirm nonhematologic malignancy Hepatocellular Carcinoma ( HCC ) . 3 . Eastern Cooperative Oncology Group ( ECOG ) Performance Score 02 . 4 . Subject must adequate bone marrow , renal hepatic function follow : Bone Marrow : Absolute neutrophil count ( ANC ) &gt; = 1,500/mm^3 ( 1.5 X 10^9/L ) ; Platelets &gt; = 75,000/mm^3 ( 75 X 10^9/L ) ; Hemoglobin &gt; = 9.0 g/dL ( 1.4 mmol/L ) Renal function : serum creatinine &lt; = 2.0 mg/dL ( 0.81 mmol/L ) ; Hepatic function : AST ALT &lt; = 1.5 X ULN unless liver metastasis present , AST ALT &lt; = 5.0 X ULN ; bilirubin &lt; = 1.5 mg/dL ( 0.026 mmol/L ) 5 . Subject must Partial Thromboplastin Time ( PTT ) &lt; /= 1.5 x Upper Limit Normal ( ULN ) International Normalized Ratio ( INR ) &lt; /= 1.5 . Exclusion Criteria 1 . Subject receive anticancer therapy include investigational agent , cytotoxic chemotherapy , radiation therapy biologic therapy within 21 day within period define 5 half life , whichever short , prior study drug administration . In addition subject recover less equal Grade 1 clinically significant adverse effects/toxicities previous therapy . 2 . Subject undergone major surgery within 21 day Period 1 , Study Day 1 . 3 . Subject untreated brain meningeal metastasis . Subjects treat brain metastasis radiographically clinically stable ( least 4 week therapy ) evidence cavitation hemorrhage brain lesion , eligible provide asymptomatic require corticosteroid ( must discontinue steroid least 1 week prior Study Day 1 , Period 1 ) . 4 . Current enrollment another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>